... What does it mean? Something? Nothing? Obviously DVAX says there's no dispute, but Mark was the officer who took profits from 6 million shares a month before adcom and was obviously right on that. Also, its is odd that this would be announced right now. Typically strange things before an approval are taken as a negative signal (i.e., the cancellation of a CLSN presentation in a conference just before they announced the failure of Thermodox last week). I dont know if Im just being paranoid, but I do wish this announcement came after PDUFA. It makes me feel nervous. Any THOUGHTFUL opinions? Thanks
Impossible to read. So many scenarios:
1. His usefulness was exhausted/goals met
2. Big equity partners repositioning for massive ramp up
3. Heplisav failure and he's a scapegoat (doesn't make sense)
4. Big equity partner has negotiated rights to board seat upon certain criteria having been met.
My read is that if Dynavax was going down this action would not have been taken. If Heplisav and Dynavax were headed to the big leagues, a change in management/board would be first on the agenda.
To me this appears to be telegraphing a repositioning for bigger things to come.